Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.

Wood, Georgina; Grenader, Tal; Nash, Stephen; Adams, Richard; Kaplan, Richard; Fisher, David; Maughan, Tim; Bridgewater, John; (2017) Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study. Anti-Cancer Drugs, 28 (5). pp. 546-550. ISSN 0959-4973 DOI: https://doi.org/10.1097/CAD.0000000000000488

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1097/CAD.0000000000000488

Abstract

Share

Download

Filename: Wood_etal_2017_derived_neutrophil.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar